Erratum: Alveolar soft-part sarcoma of paranasal sinuses (International Journal of Surgical Pathology (2011) 19:5 DOI: 10.1177/1066896911409575);Mesothelin and GPR30 staining among a spectrum of pancreatic epithelial neoplasms

International Journal of Surgical Pathology

Volumn 19, Issue 5, 2011, Pages 588-596

  Glass, Joseph P ^a   Parasher, Gulshan ^a   Arias Pulido, Hugo ^a   Donohue, Rachel ^a   Cerilli, Lisa A ^a   Prossnitz, Eric R ^a  

^a UNIVERSITY OF NEW MEXICO SCHOOL OF MEDICINE   (United States)

Author keywords

adenocarcinoma; GPR30; mesothelin; neoplasm; pancreas

Indexed keywords

ESTROGEN RECEPTOR; G PROTEIN COUPLED RECEPTOR 30; MESOTHELIN;

ARTICLE; ASPIRATION BIOPSY; BILE DUCT TUMOR; CHRONIC PANCREATITIS; CYSTADENOMA; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INTRADUCTAL PAPILLARY MUCINOUS TUMOR; MAJOR CLINICAL STUDY; PANCREAS ADENOCARCINOMA; PANCREAS CYST; PANCREAS PSEUDOCYST; PANCREAS TUMOR; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY;

EID: 81555207563     PISSN: 10668969     EISSN: 19402465     Source Type: Journal    
DOI: 10.1177/1066896912445704     Document Type: Erratum

References (11)

1. Agarwal B, Ludwig OJ, Collins BT, Cortese C. Immunostaining as an adjunct to cytology for diagnosis of pancreatic adenocarcinoma. Clin Gastroenterol Hepatol. 2008 ; 6: 1425-1431
2. Argani P, Iacobuzio-Donahue C, Ryu B, et al. Mesothelin is overexpressed in the vast majority of ductal adenocarcinomas of the pancreas: identification of a new pancreatic cancer marker by serial analysis of gene expression (SAGE). Clin Cancer Res. 2001 ; 7: 3862-3868 (Pubitemid 34044602)
3. Baruch AC, Wang H, Staerkel GA, Evans DB, Hwang RF, Krishnamurthy S. Immunocytochemical study of the expression of mesothelin in fine-needle aspiration biopsy specimens of pancreatic adenocarcinoma. Diagn Cytopathol. 2007 ; 35: 143-147 (Pubitemid 46355345)
4. Hassan R, Laszik ZG, Lerner M, Raffeld M, Postier R, Brackett D. Mesothelin is overexpressed in pancreaticobiliary adenocarcinomas but not in normal pancreas and chronic pancreatitis. Am J Clin Pathol. 2005 ; 124: 838-845 (Pubitemid 41740183)
5. Jhala N, Jhala D, Vickers SM, et al. Biomarkers in diagnosis of pancreatic carcinoma in fine-needle aspirates. Am J Clin Pathol. 2006 ; 126: 572-579
6. McCarthy DM, Maitra A, Argani P, et al. Novel markers of pancreatic adenocarcinoma in fine-needle aspiration: mesothelin and prostate stem cell antigen labeling increases accuracy in cytologically borderline cases. Appl Immunohistochem Mol Morphol. 2003 ; 11: 238-243 (Pubitemid 37082060)
7. Zhu QY, Li ZS, Pan X, Sun ZX. Expression and diagnostic value of mesothelin in specimen of pancreas fine-needle aspiration [in Chinese]. Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 2005 ; 27: 615-618
8. Revankar CM, Cimino DF, Sklar LA, Arterburn JB, Prossnitz ER. A transmembrane intracellular estrogen receptor mediates rapid cell signaling. Science. 2005 ; 307: 1625-1630 (Pubitemid 40354745)
9. Filardo EJ, Quinn JA, Frackelton AR, Bland KI. Estrogen action via the G protein-coupled receptor, GPR30: stimulation of adenylyl cyclase and cAMP-mediated attenuation of the epidermal growth factor receptor-to-MAPK signaling axis. Mol Endocrinol. 2002 ; 16: 70-84 (Pubitemid 34044499)
10. Smith HO, Arias-Pulido H, Kuo DY, et al. GPR30 predicts poor survival for ovarian cancer. Gynecol Oncol. 2009 ; 114: 465-471
11. Smith HO, Leslie KK, Singh M, et al. GPR30: a novel indicator of poor survival for endometrial carcinoma. Am J Obstet Gynecol. 2007 ; 196: 386.e1-386.e9